Mario Scartozzi

Mario Scartozzi

Università degli Studi di Cagliari - Cagliari / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1800971
University of Cagliari
person_outline Mario Scartozzi's MOST POPULAR ARTICLES
1-) PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancerF Loupakis, L Pollina, I Stasi, A Ruzzo, M Scartozzi, D Santini, G Masi, ...Journal of clinical oncology 27 (16), 2622-2629, 20094972009
2-) Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumabM Scartozzi, E Galizia, S Chiorrini, R Giampieri, R Berardi, C Pierantoni, ...Annals of oncology 20 (2), 227-230, 20093762009
3-) Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with …M Scartozzi, I Bearzi, R Berardi, A Mandolesi, G Fabris, S CascinuJournal of clinical oncology 22 (23), 4772-4778, 20043272004
4-) Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 studyS Qin, SL Chan, S Gu, Y Bai, Z Ren, X Lin, Z Chen, W Jia, Y Jin, Y Guo, ...The Lancet 402 (10408), 1133-1146, 20232432023
5-) Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?D Santini, B Vincenzi, R Addeo, C Garufi, G Masi, M Scartozzi, A Mancuso, ...Annals of Oncology 23 (9), 2313-2318, 20122352012